GSC
NEUE

G&S Capital’s NeueHealth NEUE Stock Holding History

G&S Capital’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-171
Closed -$3.02K – 138
2023
Q1 		$3.02K Sell
171
-1
-0.6% -$52 ﹤0.01% 108
2022
Q4 		$8.95K Buy
172
+1
+0.6% +$73 ﹤0.01% 105
2022
Q3 		$14K Hold
171
– – 0.01% 92
2022
Q2 		$25K Buy
+171
New +$24.9K 0.01% 88

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

G&S Capital's NEUE Position: Q2 2023 in Review

G&S Capital sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 171 shares — an estimated $3.02K sold.

G&S Capital first reported a position in NEUE in Q2 2022 and held it in 4 quarters. The position peaked at $25K in Q2 2022. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • G&S Capital reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • G&S Capital sold 171 NeueHealth shares in Q2 2023, an estimated $3.02K.
  • G&S Capital first reported a position in NeueHealth in Q2 2022 and held it in 4 quarters.
  • G&S Capital's NeueHealth position peaked at $25K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on G&S Capital's 13F filing for Q2 2023, filed 26 Jul 2023.